MEDICANNA BY DOCTEL · AUSTRALIA
Medicanna by DocTel
Private telehealth consultations focused on your health history, current care and appropriate next steps. An independent Australian-registered practitioner assesses whether remote care is suitable, whether more information is needed and whether another clinical pathway would be safer or more appropriate.
Care with clear expectations
Four principles explain what the service provides, who makes decisions and why no clinical outcome is promised before an assessment.
Australian-registered practitioners
Clinical decisions remain with the treating practitioner, who applies professional judgement to the information available.
Private telehealth consultations
A confidential setting for discussing your health, current medicines, previous care and priorities without assuming a particular treatment.
Individual clinical assessment
Suitability and next steps are considered for each person, including risks, interactions, alternatives and whether telehealth is adequate.
Clear next-step guidance
The outcome may include further records or investigations, in-person care, referral, follow-up or another pathway.
A CONVERSATION WITH CONTEXT
Care can feel clearer when the whole story has space
People often arrive after months or years of appointments, changing symptoms or unanswered questions. Medicanna offers a structured consultation where you can explain what has happened so far, what has been tried, what medicines you currently use and what matters in daily life. Relevant reports, diagnoses and treatment history can help the practitioner understand the broader clinical context.
“Good care begins with understanding the whole picture—not rushing towards a particular outcome.”
The practitioner may recommend further records, investigations, face-to-face review, referral or a different care pathway. Being heard does not predetermine the clinical decision; it helps make that decision properly informed. If remote assessment cannot safely answer the clinical question, telehealth may not be the appropriate setting.
START WITH THE HEALTH CONCERN
Explore health concerns and clinical pathways
These guides begin with symptoms, context and appropriate assessment—not a predetermined treatment. They provide general educational information about common contributors, warning signs and questions worth raising with a registered practitioner. They do not diagnose a condition, determine eligibility or indicate that medicinal cannabis is suitable for any particular concern.
Persistent pain and mobility
Explore common contributors to ongoing pain, important warning signs, assessment approaches and questions to discuss with a registered practitioner. Persistent pain can have multiple causes and requires individual assessment.
Sleep difficulties
Understand patterns that can affect sleep, when further investigation matters and how a clinician may approach persistent sleep concerns. The guide is educational and does not recommend a treatment.
Stress and emotional wellbeing
Learn about clinical assessment, urgent warning signs and the range of care pathways that may be considered for emotional wellbeing concerns. Some situations need urgent or specialist support.
Neurological symptoms
Review general information about neurological concerns, the importance of diagnosis and circumstances that require urgent or specialist care. New or rapidly changing symptoms may require prompt in-person assessment.
Women's health concerns
Explore assessment considerations for persistent symptoms affecting women’s health, including when face-to-face examination, investigation or specialist review is appropriate. The guide does not establish suitability for any medicine.
Supportive and palliative care
Understand how individual goals, existing care teams and careful clinical assessment shape supportive and palliative care discussions. Decisions should be coordinated with the clinicians already involved in care.
How the Medicanna pathway works
Four considered stages from initial information to an appropriate next step—without a product menu, self-selection pathway or predetermined outcome.
Already reviewed the eligibility criteria?
1 · Share initial information
Provide relevant health information and arrange a consultation. Initial forms support preparation but do not determine eligibility, diagnose a condition or replace clinical assessment. Accurate details help the practitioner decide what can safely be assessed by telehealth.
2 · Meet your practitioner
Discuss your symptoms, relevant diagnoses, duration and functional impact, previous treatments, current medicines, allergies and important safety factors during a private telehealth appointment. The practitioner may ask for supporting records or clarification.
3 · Discuss appropriate options
The practitioner considers the clinical picture, potential benefits and harms, medicine interactions, contraindications, reasonable alternatives and whether telehealth provides enough information for a safe decision.
4 · Agree on the next step
The outcome may be a treatment plan, a request for more information, follow-up, face-to-face care, referral or another pathway. A consultation does not guarantee a prescription, a particular medicine or a specific outcome.
INDEPENDENT CLINICAL JUDGEMENT
Care decisions based on your clinical picture
Regulatory access to medicinal cannabis is not the same as clinical approval for an individual patient, and access pathways do not establish that treatment is suitable.
Medicanna is a clinical assessment service, not a product-selection or automatic-approval pathway. Each decision is made for the individual patient after reviewing potential benefits, risks, interactions, contraindications, available evidence and reasonable alternatives. Prescribing, if considered, remains a separate clinical decision and may require additional regulatory steps.
Read how online prescription assessment works or review the broader Australian medicinal cannabis telehealth pathway.
INFORMED BEFORE YOU BOOK
Understand the pathway, cost and safety
Make an informed decision before paying for a consultation. DocTel provides separate guidance on consultation and treatment costs, TGA access pathways and prescriber obligations, and patient safety, impairment and quality standards. Federal therapeutic-goods pathways operate alongside separate state and territory prescribing, controlled-medicine and driving laws, so the rules relevant to your location and circumstances should be checked before booking.
People arriving through informal search terms can use the medical marijuana terminology guide to understand how those terms map to the Australian clinical framework. General website information cannot replace advice from your treating practitioner.
Research the pathway before you commit
Medicanna sits inside DocTel's wider medicinal cannabis service. These pages explain the pathway, costs, safety considerations and regulatory context in more detail. Read the information relevant to your circumstances before deciding whether to request a consultation; the linked resources are educational and do not determine clinical suitability.
STATE & TERRITORY GUIDANCE
Information relevant to where you live
Medical cannabis consultations: common questions
What happens during a medical cannabis consultation?
A medical cannabis consultation is a clinical assessment, not a product-selection appointment. The practitioner reviews your symptoms, diagnoses, medical history, current medicines, previous treatments, treatment goals and relevant safety factors before discussing appropriate options. More information, investigations, referral or face-to-face care may be recommended.
Can medicinal cannabis be prescribed through telehealth in Australia?
Telehealth can be used when the practitioner considers that a safe and adequate assessment can be completed remotely. An online appointment does not guarantee a prescription. Supporting records, further investigation or an in-person examination may be required before any prescribing decision is made.
Who is authorised to prescribe medicinal cannabis in Australia?
Australian medical practitioners and nurse practitioners may prescribe within their professional scope and the applicable regulatory pathway. Unapproved products generally require access through the Special Access Scheme or Authorised Prescriber pathway, together with any relevant state or territory requirements. The individual prescriber remains responsible for the clinical decision.
Does a medical cannabis consultation guarantee a prescription?
No. The consultation fee pays for the practitioner’s time and clinical assessment—not for approval or a prescription. The practitioner may decide that medicinal cannabis is unsuitable, that further information is required or that another treatment, specialist service or face-to-face assessment would be more appropriate.
How does a practitioner assess medicinal cannabis suitability?
The assessment may consider symptoms, duration, functional impact, diagnoses, previous treatments, current medicines and supplements, allergies, mental-health history, substance-use risk, pregnancy or breastfeeding, potential interactions and other contraindications. Suitability is an individual clinical decision and cannot be established by an online questionnaire alone.
Is medicinal cannabis considered an alternative treatment?
Medicinal cannabis is sometimes described as an alternative or complementary treatment, but in Australia it is regulated as prescription medicine. Calling it “natural therapy” does not remove its risks, interactions or prescribing requirements. A practitioner must consider the available evidence and whether other established treatment options remain appropriate.
How much does a medical cannabis consultation cost?
Consultation and follow-up fees are separate from pharmacy dispensing, medicine and delivery costs. The total expense depends on the clinical pathway and any medicine ultimately prescribed. Review the medicinal cannabis cost guide before booking so the separate charges are clear.
What happens after a medicinal cannabis prescription is issued?
If prescribing is clinically appropriate, the prescription is sent through the applicable process for dispensing by a pharmacy. DocTel does not manufacture or dispense medicinal cannabis. Product availability, pharmacy charges, dispensing time and delivery arrangements are separate from the consultation service and should be confirmed with the dispensing pharmacy.
Can I drive after taking prescribed medicinal cannabis?
Medicinal cannabis can affect alertness, coordination and reaction time. Products containing THC may create additional legal risk because driving laws differ between Australian jurisdictions and a prescription may not provide a defence to roadside drug-driving rules. Discuss impairment, your product and your driving needs with the prescriber.
Do medicinal cannabis rules differ between Australian states?
Yes. Commonwealth therapeutic-goods requirements interact with state and territory rules covering prescribing, controlled medicines, dispensing and driving. The applicable requirements depend on where the patient and practitioner are located. Use the state and territory guides on this page for more specific information.
How is a medical cannabis consultation different from a general GP appointment?
A medical cannabis consultation focuses on whether this specific clinical pathway is appropriate after reviewing relevant history, previous treatment and safety factors. A general GP consultation addresses broader healthcare needs. The cannabis practitioner may still recommend that you return to your regular GP, seek specialist advice or arrange an examination.
What should I prepare for an online cannabis consultation?
Have your diagnoses, medical history, current medicines and supplements, allergies, previous treatment results and relevant reports available. Be ready to explain how symptoms affect daily function and what has already been tried. Use a quiet private space and do not delay urgent or necessary in-person care while waiting.
Move forward with clear expectations
Begin with reliable information, then decide whether requesting a private clinical consultation is the right next step. The practitioner remains free to recommend further investigation, in-person assessment, referral or a different form of care.
If you need urgent care
Medicanna provides scheduled telehealth assessment, not emergency care. If you are experiencing a medical emergency, call 000. For urgent but non-emergency concerns, contact your GP, a local hospital emergency department, or an appropriate crisis service. Telehealth is not suitable for every clinical situation, and your practitioner may recommend in-person examination, further investigations, or another service where a remote assessment is not appropriate.